Clinical Trial

Human Skin Safety Testing of 1 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers

Study acronym: GLOW-Safety-4
Completed
View on ClinicalTrials.gov →
Summary
The objective of this study is to investigate the irritation and sensitization potential of 1 topically applied test article containing Mitopure in a shared panel of healthy volunteers by means of repeated cutaneous patch applications under occlusion based on the modified Draize method
Protocol Amendment History 5 changes
critical Trial completed 2026-06-18
notable Enrollment increased: 100 -> 112 participants 2026-06-18
notable Primary completion moved earlier: 2026-09-15 -> 2026-06-01 2026-06-18
minor Completion moved earlier: 2026-09-15 -> 2026-06-01 2026-06-18
critical Recruitment opened 2026-04-30
Trial Details
NCT Number NCT07517874
Lead Sponsor Amazentis SA
Collaborators: Princeton Consumer Research
Conditions Irritation/Irritant, Sensitisation
Enrollment 112 participants
Start Date 2026-04-20
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-17